UNICANCER-PRODIGE-23-trial-185485-slide-ppt

Slide1PresentedByThierryConroyatTBDBackground:stageII/IIIrectalcancer(T3-4,N0orN+)br/PresentedByThierryConroyatTBDSlide3PresentedByThierryConroyatTBDKeyInclusionCriteriaPresentedByThierryConroyatTBDKeyExclusionCriteriaPresentedByThierryConroyatTBDEndpointsPresentedByThierryConroyatTBDStatisticalconsiderationsPresentedByThierryConroyatTBDRecruitmentandanalysisPresentedByThierryConroyatTBDFlowchartPresentedByThierryConroyatTBDPatientsbaselinecharacteristicsPresentedByThierryConroyatTBDBaselinecharacteristicsoftumorsPresentedByThierryConroyatTBDSlide12PresentedByThierryConroyatTBDChemoradiotherapycomplianceandsafetyPresentedByThierryConroyatTBDSlide14PresentedByThierryConroyatTBDSlide15PresentedByThierryConroyatTBDSlide16PresentedByThierryConroyatTBDSlide17PresentedByThierryConroyatTBDSlide18PresentedByThierryConroyatTBDDisease-FreeSurvivalPresentedByThierryConroyatTBDPrognosticfactorsforDFSPresentedByThierryConroyatTBDSlide21PresentedByThierryConroyatTBDSlide22PresentedByThierryConroyatTBDSlide23PresentedByThierryConroyatTBDConclusionsPresentedByThierryConroyatTBDPresentedByThierryConroyatTBDAcknowledgementsPresentedByThierryConroyatTBD